mFOLFOX6+Cetuximab in Treating Patients With not Optimally Resectable Liver Metastases From Colorectal Cancer
Phase 2
Recruiting
- Conditions
- liver metastases from colorectal cancer
- Registration Number
- JPRN-UMIN000004811
- Lead Sponsor
- Cancer Institute Hospital of Japanese Foundation for Cancer Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1) No severe heart disease 2) No past history of AMI within 6 months 3) Not pregnant 4) Uncontrolled infectious disease 5) No systemic steroids or immunosupressant 6) No severe drug allergy 7) No psychological, familial, social, or geographical condition that would preclude study compliance 8) No symptomatic effusion collection 9) No severe peripheral neuropathy 10) No watery diarrhea 11) No other significant disease that would preclude study participationr
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall response rate
- Secondary Outcome Measures
Name Time Method R0 resection rate, safety, DFS, OS